Lakewood-Amedex Biotherapeutics Inc.
For the period ended Apr 24, 2026. Filed Apr 28, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Apr 24, 2026 · Filed Apr 28, 2026
LABT$0.39-28.5%Stored close · as of Nov 6, 2026
Contents
Cover page
Show cover page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.